Delivery Order SPE2DB24D1205-SPE2DB25FDADG
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,342.98 to AmerisourceBergen Drug Corp for the supply of Crexont ER 70 mg-280 mg capsules (120 count) on July 21, 2025, with ultimate completion scheduled for July 22, 2025. This non-set-aside, firm fixed-price delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for CREXONT ER 70 mg–280 mg capsules (120-count packaging) with a ceiling value of $3,237.83. This firm fixed-price delivery order is non-competitive, representing one of numerous pharmaceutical supply transactions executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,590.02 on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price contract, issued by the Defense Logistics Agency's Medical Supply Chain, represents a non-set-aside competitive award. The delivery order is performed at the awardee's corporate office location in Conshohocken, Pennsylvania, and follows the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $70,980 on July 22, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, which is set to be completed by July 23, 2025, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,185.65 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a child delivery order under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,051.40 on July 21, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for ultimate completion on July 22, 2025, with performance taking place at the vendor's Conshohocken facility. The award was competitively procured with no...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,259.07 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025. This firm fixed price contract, which carries an ultimate completion date of September 4, 2025, represents a child order under the company's larger pharmaceutical supply vehicle. The award was competitively procured with no set-aside designation and will be performed at the vendor's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $125,954.90 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025. This firm fixed-price contract, which is a child order under a larger indefinite delivery contract vehicle, carries an ultimate completion date of August 8, 2025. The award was made through competitive procurement with no set-aside designation, reflecting the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,470.85 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is non-competitive and scheduled for ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $47,315.38 by the Defense Logistics Agency's Medical Supply Chain on August 27, 2025. This firm fixed-price contract, which is a child order under a larger indefinite delivery vehicle, represents a non-competitive award with an ultimate completion date of August 28, 2025. The contract will be performed at the company's corporate office location in...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDADGDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $3,642.37 delivery order by the Defense Logistics Agency (DLA) on September 4, 2025, for the supply of Crexont ER 70 MG-280 MG capsules (120-count). The contract is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located at the awardee's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single-item pharmaceutical procurement under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. As a critical pharmaceutical vendor for federal medical procurement, AmerisourceBergen Drug Corp consistently fulfills federal requirements through open competition, delivering both brand-name and generic medications across multiple therapeutic domains to support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/4/25 |